发明名称 S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY
摘要 <p>Provided herein are compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. In certain embodiments, the enhanced bioavailability formulations provided herein may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease.</p>
申请公布号 EP2512490(A4) 申请公布日期 2012.12.26
申请号 EP20100803973 申请日期 2010.07.29
申请人 MSI METHYLATION SCIENCES INC. 发明人 MACDONALD, I., DAVID;HARRISON, NANCY;TAKACS-COX, ANIKO;PURAC, ADMIR;BLAZEK-WELSH, ALMIRA
分类号 A61K31/7076;A61K9/20;A61K9/28;A61K47/06;A61K47/12;A61K47/14;A61K47/18;A61K47/40 主分类号 A61K31/7076
代理机构 代理人
主权项
地址